Generation of DC-based vaccine for therapy of B-CLL patients. Comparison of two methods for enriching monocytic precursors
/in Chronic Leukemia, Dendritic Cells, International Publications /von 2006-01-01 / Cytotherapy 2006;8(4):318-26Production of myeloid dendritic cells (DC) pulsed with tumor-specific idiotype protein for vaccination of patients with multiple myeloma
/in Dendritic Cells, International Publications, Multiple Myeloma /von 2006-01-01 / Cytotherapy 2006;8(3):277-89Dendritic cell immunizations alone or combined with low doses of interleukin-2 induce specific immune responses in melanoma patients
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2005-12-01 / Clin. Exp. Immunol. 2005 Dec;142(3):555-68Vaccine strategies to treat lymphoproliferative disorders
/in Chronic Leukemia, Dendritic Cells, International Publications, Malignant Lymphoma, Multiple Myeloma /von 2005-12-01 / Pathology 2005 Dec;37(6):534-50Enhancement of antitumor immunity of dendritic cells pulsed with heat-treated tumor lysate in murine pancreatic cancer
/in Dendritic Cells, Hyperthermia, International Publications /von 2005-11-15 / Immunol. Lett. 2006 Mar;103(2):142-8Medullary thyroid carcinoma: autologous tumor cell lines for dendritic cell vaccination
/in Dendritic Cells, International Publications, Thyroid Cancer /von 2005-11-01 / Anticancer Res. 2005 Nov-Dec;25(6B):4225-30Combination therapy with tumor cell-pulsed dendritic cells and activated lymphocytes for patients with disseminated carcinomas
/in Dendritic Cells, International Publications /von 2005-11-01 / Anticancer Res. 2005 Nov-Dec;25(6A):3771-6HPV16/18 E7-pulsed dendritic cell vaccination in cervical cancer patients with recurrent disease refractory to standard treatment modalities
/in Cervical Cancer, Dendritic Cells, International Publications /von 2005-10-24 / Gynecol Oncol 2006 Mar;100(3):469-78[In vitro anti-myeloma effects induced by myeloma idiotype-protein pulsed dendritic cell vaccine]
/in Dendritic Cells, International Publications, Multiple Myeloma /von 2005-10-01 / Zhonghua Xue Ye Xue Za Zhi 2005 Oct;26(10):593-7
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de